FDA Leader Says He Has No Plan to Act on Abortion Pill Access

Food and Drug Administration Commissioner Marty Makary said he has no plans to change government policy on the abortion pill mifepristone, a hot-button issue in the US since the Supreme Court overturned the landmark Roe v. Wade decision in 2022.

Makary would reconsider the issue if new data emerged that signaled a safety issue with the drug that is now used in more than half of US abortions, he said during an appearance at the Semafor World Economy Summit on Thursday.

While anti-abortion groups have sought to restrict access to mifepristone, the Supreme Court preserved full access to it in ...